Healthcare

in committee · New Jersey · General Assembly Jan 13, 2026

A 2281: Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

This bill requires New Jersey Medicaid to cover fertility preservation services (like egg or sperm freezing) for individuals who develop infertility as a direct result of medically necessary treatments, such as cancer therapy. It directly affects Medicaid beneficiaries facing treatment-induced infertility who would otherwise pay out-of-pocket for these services. The key provision amends Medicaid coverage to include these services under "comprehensive medical care" when recommended by a physician prior to treatments known to cause infertility. The policy change ensures coverage for fertility preservation as part of standard medical care, without adding new administrative burdens to existing Medicaid services.

Topics ✓ HealthcareSupports HealthcareBill mandates Medicaid coverage for fertility preservation services, expanding insurance coverage and improving patient access for treatment-induced infertility without out-of-pocket costs.95% confidence

Sub-Topics Medicaid

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 538: "Pharmaceutical Representative Licensing Act."

This bill (A 538, "Pharmaceutical Representative Licensing Act") requires all individuals marketing pharmaceuticals to healthcare practitioners in New Jersey to obtain a state license. It directly affects pharmaceutical sales representatives, who must meet education, ethics, and background requirements, complete biennial continuing education (including opioid safety training), and report all interactions with doctors - including promoted drugs, samples given, and gifts provided. The State Board of Medical Examiners will oversee licensing, enforce standards (like banning deceptive marketing or false medical credentials), and may suspend licenses for violations. The bill aims to increase transparency and professionalism in pharmaceutical sales interactions.

Topics ✓ HealthcareSupports HealthcareRegulates pharmaceutical marketing with ethics training, transparency, and opioid safety requirements to protect patient safety and promote ethical healthcare interactions.85% confidence

Sub-Topics Substance Abuse Tags Licensing

Track

in committee · New Jersey · Senate May 18, 2026

S 3502: Requires health insurance and Medicaid coverage for treatment of stuttering.*

S 3502 requires all health insurance plans and Medicaid in New Jersey to cover stuttering treatment, including both habilitative (helping learn or maintain speech skills) and rehabilitative (restoring lost speech skills) speech therapy. It mandates coverage for in-person and telehealth services without cost-sharing like deductibles, copays, or annual limits, and eliminates prior authorization requirements. This directly affects all New Jersey residents with health insurance or Medicaid who need speech therapy for stuttering. The bill applies to all relevant insurance contracts issued in the state, ensuring consistent coverage for medically necessary stuttering treatment.

Topics ✓ HealthcareSupports HealthcareRequires insurance/Medicaid coverage for stuttering treatment, eliminating cost-sharing and prior authorization, expanding access to speech therapy services.95% confidence

Sub-Topics Insurance Medicaid Telehealth

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 1155: Establishes State Parkinson's disease registry.

New Jersey's Bill A1155 establishes a statewide Parkinson's disease registry to track the incidence and prevalence of Parkinson's disease and related conditions (Parkinsonisms) across the state. Health care providers must report diagnosed cases to the registry, including diagnostic details, treatment, and survival data, while allowing patients to opt out in writing. The registry collects only necessary health information, removes personal identifiers through coding, and strictly protects confidentiality - preventing disclosure in legal proceedings or for unauthorized uses. This data will support research, public health planning, and potentially improve care for those affected, with all reporting requirements applying to cases diagnosed both before and after the bill's effective date.

Topics ✓ HealthcareSupports HealthcareEstablishes public health registry for Parkinson's disease, tracking incidence/prevalence to improve disease data collection and inform healthcare strategies, aligning with public health program support.95% confidence

Sub-Topics Public Health

Track

in committee · New Jersey · General Assembly Jan 13, 2026

AR 16: Urges Congress to compel Department of Health and Human Services to fulfill its obligations pursuant to the National Childhood Vaccine Injury Act of 1986.

AR 16 is a New Jersey Assembly resolution urging Congress to require the U.S. Department of Health and Human Services (HHS) to comply with the National Childhood Vaccine Injury Act of 1986 (NCVIA). Specifically, it calls for HHS Secretary to submit the legally mandated biennial reports detailing actions taken to improve vaccine safety, which HHS has not done since 1989. The resolution does not create new requirements but seeks to compel HHS to fulfill existing obligations under the NCVIA. It directly affects HHS and Congress, as it requests congressional action to enforce the law. This is a procedural resolution, not a policy change.

Topics ✓ HealthcareSupports HealthcareUrges HHS compliance with vaccine safety reporting under NCVIA, protecting public health and patient safety through enforcement of existing healthcare obligations.95% confidence

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 2718: Requires continued coverage of prescription drugs for certain medical conditions.

This bill requires health insurers in New Jersey to maintain coverage for prescription drugs for individuals with complex/chronic medical conditions or rare diseases during any appeal stage if coverage was previously denied based on medical necessity. It prevents insurers from imposing new cost increases, coverage limits, or moving drugs to higher-cost tiers while an appeal is pending. Insurers may only deny coverage during an appeal if the prescribing doctor stops recommending the drug, the FDA issues a safety warning, or the drug manufacturer discontinues production. The law applies to all group and individual health insurance plans sold in New Jersey that cover prescription drugs.

Topics ✓ HealthcareSupports HealthcareMandates insurers maintain coverage during appeals for chronic/rare disease drugs, prevents cost increases, and protects patient access to necessary medications.95% confidence

Sub-Topics Insurance

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3179: Provides civil immunity to licensed health care professionals who provide care at health care facilities for no compensation.

This bill (A 3179) grants civil immunity to licensed health care professionals who provide unpaid care at licensed health care facilities or nonprofit clinics, protecting them from lawsuits for personal injury resulting from that care. It applies to professionals like doctors, nurses, dentists, and therapists who do not bill for or expect payment for their services. The immunity does not cover cases of gross negligence or willful misconduct, as proven by clear evidence. Before providing care, professionals must inform patients about this immunity, and the law takes effect 60 days after enactment.

Topics ✓ HealthcareSupports HealthcareProtects volunteers from lawsuits, encouraging unpaid care access at clinics and supporting healthcare delivery.85% confidence

Track

died · New Jersey · General Assembly Jan 13, 2026

A 3432: Requires certain preventive services to be provided on calendar year basis.

This bill (A 3432) requires health insurance plans in New Jersey (both hospital and medical service corporation contracts) to cover specific preventive services without cost-sharing. It mandates coverage for USPSTF "A"/"B" rated services, CDC-recommended immunizations, pediatric care guidelines, and women's preventive services, with coverage required at least once per calendar year (not policy year). Plans must cover out-of-network services when no in-network provider is available for covered services, and coverage begins one year after a new recommendation is issued. The bill affects all applicable insurance contracts issued or renewed in New Jersey, ensuring broader access to preventive care without patient cost-sharing for these specific services. (Note: The bill was withdrawn after being approved as P.L.2025, c.386.)

Topics ✓ HealthcareSupports HealthcareMandates no cost-sharing for USPSTF 'A'/'B' preventive services, CDC immunizations, and women's care, expanding access to essential healthcare without policy year limitations.95% confidence

Sub-Topics Children's Health Hospitals Insurance

Track

passed · New Jersey · General Assembly May 4, 2026

A 948: Requires DOH to conduct survey on status of antenatal and prenatal care clinics in New Jersey.

This bill requires New Jersey's Department of Health (DOH) to survey all antenatal and prenatal care clinics across the state - including those that have closed or reduced services in the past two years - to evaluate maternity care access and quality. The survey will collect data on clinic availability, service gaps (particularly for low- and moderate-income pregnant women), and demographic information about patients, while excluding personal health details. The DOH must analyze the data to identify disparities in care based on income or location and develop strategies to improve access and quality. Within 18 months, the DOH will publish findings online and submit a report to the legislature with recommendations for policy action.

Topics ✓ HealthcareSupports HealthcareBill mandates DOH survey to assess maternity care access gaps for low-income patients, aiming to improve service quality and availability in healthcare access.90% confidence

Sub-Topics Primary Care Women's Health

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3944: Revises requirements for assessing nursing home health, safety, and operations and for taking action against low-performing nursing homes.

This New Jersey bill (A3944) creates new performance standards for nursing homes, directly affecting facilities that receive federal one-star ratings or fail to meet metrics in three key areas: resident physical health (e.g., bedsores, falls), mental well-being (e.g., medication use, depression), and operational factors (e.g., staff turnover, vaccination rates). It establishes a tiered response system: a warning for first failures, sanctions like restricting Medicaid admissions for repeated failures, and severe penalties including removing Medicaid residents or suspending payments for persistent underperformance. Nursing homes failing standards in three of four consecutive quarters must submit a 18-month improvement plan for state review. The bill aims to strengthen accountability for nursing home quality without specifying expected outcomes.

Topics ✓ HealthcareSupports HealthcareBill establishes stricter performance standards for nursing homes, targeting resident health outcomes (physical/mental) and operations, directly strengthening care quality and accountability in healthcare services.92% confidence

Sub-Topics Long-Term Care Medicaid Public Health

Track